- £19.54m
- £65.34m
- £84.87m
- 47
- 81
- 95
- 89
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 62.4 | 67.5 | 78.1 | 96.5 | 84.9 |
Cost of Revenue | |||||
Gross Profit | 12.5 | 13.6 | 12.1 | 14.1 | 10.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 57.2 | 63.3 | 80.7 | 93.2 | 80.7 |
Operating Profit | 5.18 | 4.25 | -2.58 | 3.37 | 4.22 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.65 | 2.61 | -4.78 | 0.295 | 1.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.84 | 1.95 | -4.05 | 0.066 | 1.17 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.31 | 1.95 | -4.05 | 0.066 | 1.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.31 | 1.95 | -4.05 | 0.066 | 1.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.071 | 0.072 | -0.468 | -0.019 | -0.035 |
Dividends per Share | |||||
Special Dividends per Share |